Limani, P., Linecker, M., Kron, P., Samaras, P., Pestalozzi, B., Stupp, R., . . . Clavien, P. (2016). Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial. BMC Cancer.
Trích dẫn kiểu ChicagoLimani, Perparim, et al. "Development of OXY111A, a Novel Hypoxia-modifier As a Potential Antitumor Agent in Patients With Hepato-pancreato-biliary Neoplasms - Protocol of a First Ib/IIa Clinical Trial." BMC Cancer 2016.
Trích dẫn MLALimani, Perparim, et al. "Development of OXY111A, a Novel Hypoxia-modifier As a Potential Antitumor Agent in Patients With Hepato-pancreato-biliary Neoplasms - Protocol of a First Ib/IIa Clinical Trial." BMC Cancer 2016.